---
tags: ["Feminizing HRT", "Estrogens", "Injections", "DIY"]
title: "Sources on the risks of thrombosis"
linkTitle: "Sources on the risks of thrombosis"
date: 2017-01-05
weight: 6
description: >
---

{{% pageinfo %}}
Patients are usually warned about the risks of thrombosis - deep vein thrombosis and thromboembolic events. This pages gives a number of articles whose conclusions show a few things:
- Risks depends on the administration routes: transdermal and injections are safer than oral
- Risks depends on the type of estrogens: synthetic and non-bioidentical should be avoided
{{% /pageinfo %}}

[Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review](https://www.tandfonline.com/doi/full/10.1080/17425247.2020.1700949)

[Pharmacology of estrogens and progestogens: influence of different routes of administration](https://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf)

[Menopausal hormone therapy and venous thromboembolism](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520375/)

[Oral Contraceptives and HRT Risk of Thrombosis](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714678/)

[Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases](https://www.bmj.com/content/350/bmj.h2135)

[Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases](https://www.bmj.com/content/364/bmj.k4810)

[Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.](https://www.bmj.com/content/293/6544/413)

[Therapy Insight: parenteral estrogen treatment for prostate cancerâ€”a new dawn for an old therapy](https://www.nature.com/articles/ncponc0602)